Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antineoplastic agent |
| gptkbp:activeIngredient |
gptkb:cladribine
|
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:L01BB04
|
| gptkbp:CASNumber |
gptkb:4291-63-8
|
| gptkbp:hasUNII |
J50OIX65EW
|
| https://www.w3.org/2000/01/rdf-schema#label |
Leustatin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Janssen_Biotech
|
| gptkbp:PubChem_CID |
DB00242
119574 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fever
nausea immunosuppression myelosuppression |
| gptkbp:synonym |
gptkb:cladribine
gptkb:2-chlorodeoxyadenosine |
| gptkbp:usedFor |
gptkb:hairy_cell_leukemia
|
| gptkbp:bfsParent |
gptkb:Cladribine
|
| gptkbp:bfsLayer |
6
|